| Revenue growth | Q2 consolidated +14.9% YoY; H1 +10.0% YoY |
|---|---|
| Margins | Q2 business EBITDA margin 8.7%, up 4.7pp YoY |
| Demand visibility | Muted; recovery signs only towards Q4 FY27 |
| Management confidence | Cautious; navigating challenging market environment |
Growth
Q2 reported EBITDA ₹261 Cr (+125.4%). H1 revenue ₹5,385 Cr (+10.0%); H1 business EBITDA ₹487 Cr (9.0%, +4.1pp).
Outlook
Reaffirmed FY27 Acquired Group guidance: sales ~€700 Mn, EBITDA ~€35 Mn. Demand uptake expected only towards Q4 FY27.
Risks
Muted demand in US housing and European construction; high raw material costs. RIECO revenue down 21.3% YoY with cost overruns on two projects.
Last quarter's promises, checked
Delivered
- Legacy sales growth 12–13% → Pigment segment +15.8% YoY, scope not like-for-like (= BEAT)
Partly delivered
- FY27 acquired group sales €700Mn / EBITDA €35Mn → reaffirmed unchanged; no Q2 acquired-group split (= PARTIAL)
- Revisit guidance at end-Q2 → reaffirmed, not revised (= PARTIAL)
Missed
- Accelerate acquisition debt repayment; Q1 net debt ₹531 Cr → Q2 ₹580 Cr QoQ (= MISS)
- RIECO normalise from Q2, positive before FY-end → Q2 revenue ₹47 Cr (-21.3% YoY), cost overruns on two projects (= MISS)
Investor Presentation filed with NSE, NSE: SUDARSCHEM. Summary written with AI assistance from the document.
Sudarshan Chemical Industries Ltd: key numbers
- Share price
- ₹1,050.45
- Market cap
- ₹8,365 Cr
- Revenue (annual)
- ₹9,787 Cr
- Net profit (annual)
- ₹22.30 Cr
- P/E (TTM)
- 115.5×Sector 34.8×
- Promoter holding
- 9.32%+1.13% QoQ
- FII holding
- 8.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sudarshan Chemical Industries Ltd
All →Sudarshan Chemical Industries Q2 FY27 Results: Net Profit ₹30.5 Cr, Up 58.0% YoY
Sudarshan Chemical Industries Ltd reported revenue from operations of ₹2,743 Cr (+14.9% YoY) and net profit of ₹30.5 Cr (+58.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹30.5 Cr · +58.0% YoY
Sudarshan Chemical Industries Board Meeting Date
Sudarshan Chemical schedules a 6 November 2026 board meeting to consider unaudited quarterly and half-year results. Trading window stays closed until 8 November 2026.
Sudarshan Chemical Industries Merger & Restructuring Worth ₹795.9 Cr
Sudarshan Chemical completed sale of VP4 Frankfurt GmbH to Celanese for about Rs 795.9 crore. VP4 Frankfurt is no longer a step-down subsidiary.
- Value
- ₹795.9 Cr
Sudarshan Chemical Industries Employee Stock Options
Sudarshan Chemical allotted 19,350 equity shares to employees exercising options under its 2018 ESOP plan. The allotment is at an exercise price of Rs 349.35 per share.
Sudarshan Chemical Industries Credit Rating
India Ratings has revised the outlook on Sudarshan Chemical Industries' debt facilities to Positive from Stable, while affirming the existing credit ratings.
Sudarshan Chemical Industries Other Announcement
Sudarshan Chemical Industries submitted its quarterly shareholding pattern for the period ending 30 September 2026, consistent with regulatory filing requirements under Regulation 31.